VCYT

Stats

Summary

veracyte is a pioneering genomic diagnostics company. our tests are dramatically improving clinical outcomes for patients by resolving inconclusive results from traditional diagnostic methods. we ask the right questions to resolve ambiguity and bring assurance to light, rendering tens of thousands of costly and unnecessary surgeries truly unnecessary. we are giving patients a clearer path forward. through scientific rigor we employ the best tools, best science and best minds to create tests that enable a more accurate diagnosis without the need for risky, costly and often unnecessary surgery. veracyte consistently brings to bear evidence that is unprecedented in genomic tests, thereby changing today's clinical practice standards. we are making a difference in the lives of physicians and patients. we are doing something real. .

Market Cap: 1.63 Billion

Primary Exchange: NASDAQ

Website: https://www.veracyte.com/

Shares Outstanding: 73 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 2.199455897860695

Sector: Health Care and Social Assistance

Industry: Medical Laboratories

Ethical Flags

Longest drawdown: 1263 trading days

From: 2014-03-19 To: 2019-01-31

Lowest Point:

Ex-Date	Payment Date	Record Date	Declared Date	Amount	Flag	Dividend Type	Qualified	Indicated

Ex-Date	Declared Date	Record Date	Payment Date	Ratio	To Factor	For Factor